Patents by Inventor Brian D. Follstad
Brian D. Follstad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11827692Abstract: The invention provides a method for culturing mammalian cells. The method provides greater control over cell o growth to achieve high product titer cell cultures.Type: GrantFiled: March 8, 2023Date of Patent: November 28, 2023Assignee: AMGEN INC.Inventors: Brian D. Follstad, Rebecca E. McCoy, Arvia E. Morris
-
Publication number: 20230227535Abstract: The invention provides a method for culturing mammalian cells. The method provides greater control over cell o growth to achieve high product titer cell cultures.Type: ApplicationFiled: March 8, 2023Publication date: July 20, 2023Applicant: AMGEN INC.Inventors: Brian D. FOLLSTAD, Rebecca E. McCOY, Arvia E. MORRIS
-
Patent number: 11685772Abstract: The invention provides a method for culturing mammalian cells. The method provides greater control over cell growth to achieve high product titer cell cultures.Type: GrantFiled: December 14, 2022Date of Patent: June 27, 2023Assignee: AMGEN INC.Inventors: Brian D. Follstad, Rebecca E. McCoy, Arvia E. Morris
-
Patent number: 11673941Abstract: The invention provides a method for culturing mammalian cells. The method provides greater control over cell growth to achieve high product titer cell cultures.Type: GrantFiled: September 11, 2020Date of Patent: June 13, 2023Assignee: AMGEN INC.Inventors: Brian D. Follstad, Rebecca E. McCoy, Arvia E. Morris
-
Publication number: 20230129523Abstract: The invention provides a method for culturing mammalian cells. The method provides greater control over cell o growth to achieve high product titer cell cultures.Type: ApplicationFiled: December 20, 2022Publication date: April 27, 2023Applicant: AMGEN INC.Inventors: Brian D. FOLLSTAD, Rebecca E. McCOY, Arvia E. MORRIS
-
Patent number: 11634476Abstract: The invention provides a method for culturing mammalian cells. The method provides greater control over cell growth to achieve high product titer cell cultures.Type: GrantFiled: September 11, 2020Date of Patent: April 25, 2023Assignee: AMGEN INC.Inventors: Brian D. Follstad, Rebecca E. McCoy, Arvia E. Morris
-
Publication number: 20230117598Abstract: The invention provides a method for culturing mammalian cells. The method provides greater control over cell growth to achieve high product titer cell cultures.Type: ApplicationFiled: December 14, 2022Publication date: April 20, 2023Applicant: AMGEN INC.Inventors: Brian D. FOLLSTAD, Rebecca E. McCOY, Arvia E. MORRIS
-
Publication number: 20220185869Abstract: The invention provides a method for culturing mammalian cells. The method provides greater control over cell growth to achieve high product titer cell cultures.Type: ApplicationFiled: March 4, 2022Publication date: June 16, 2022Applicant: Amgen Inc.Inventors: Brian D. FOLLSTAD, Rebecca E. McCOY, Arvia E. MORRIS
-
Patent number: 11292829Abstract: The invention provides a method for culturing mammalian cells. The method provides greater control over cell growth to achieve high product titer cell cultures by changing the temperature of the cell culture and/or by starving the cells in their asparagine supply.Type: GrantFiled: June 29, 2012Date of Patent: April 5, 2022Assignee: AMGEN INC.Inventors: Brian D. Follstad, Rebecca E. McCoy, Arvia E. Morris
-
Publication number: 20210061888Abstract: The invention provides a method for culturing mammalian cells. The method provides greater control over cell growth to achieve high product titer cell cultures.Type: ApplicationFiled: September 11, 2020Publication date: March 4, 2021Applicant: Amgen Inc.Inventors: Brian D. FOLLSTAD, Rebecca E. McCOY, Arvia E. MORRIS
-
Publication number: 20200407427Abstract: The invention provides a method for culturing mammalian cells. The method provides greater control over cell growth to achieve high product titer cell cultures.Type: ApplicationFiled: September 11, 2020Publication date: December 31, 2020Applicant: Amgen Inc.Inventors: Brian D. FOLLSTAD, Rebecca E. McCOY, Arvia E. MORRIS
-
Publication number: 20140255993Abstract: The invention provides a method for culturing mammalian cells. The method provides greater control over cell growth to achieve high product titer cell cultures by changing the temperature of the cell culture and/or by starving the cells in their asparagine supply.Type: ApplicationFiled: June 29, 2012Publication date: September 11, 2014Applicant: AMGEN INC.Inventors: Brian D. Follstad, Rebecca E. McCoy, Arvia E. Morris
-
Publication number: 20110053265Abstract: This invention relates generally to the field of cell culture. More particularly, the invention relates to improving viability of recombinant cell cultures and the yields of secreted polypeptides therefrom by the addition of betaine to the tissue culture medium.Type: ApplicationFiled: November 8, 2010Publication date: March 3, 2011Inventors: Brian D. Follstad, Anne H. Potter
-
Patent number: 7829309Abstract: This invention relates generally to the field of cell culture. More particularly, the invention relates to improving viability of recombinant cell cultures and the yields of secreted polypeptides therefrom by the addition of betaine to the tissue culture medium.Type: GrantFiled: May 12, 2008Date of Patent: November 9, 2010Assignee: Immunex CorporationInventors: Brian D. Follstad, Anne H. Potter
-
Patent number: 7645609Abstract: The invention provides media and methods for culturing mammalian cells whereby the sialylation of a protein produced by the cells is increased. The medium can contain N-acetylmannosamine and, optionally, galactose. The medium may also comprise fructose and mannose. Alternatively, the medium can contain galactose and fructose and, optionally, can also comprise mannose and/or N-acetylmannosamine. The methods can be practiced along with other methods for culturing cells so as to increase the quantity or quality of a protein produced by the cells, including culturing the cells at a temperature below 37° C.Type: GrantFiled: July 15, 2003Date of Patent: January 12, 2010Assignee: Immunex CorporationInventor: Brian D. Follstad
-
Patent number: 7384765Abstract: This invention relates generally to the field of cell culture. More particularly, the invention relates to improving viability of recombinant cell cultures and the yields of secreted polypeptides therefrom by the addition of betaine to the tissue culture medium.Type: GrantFiled: May 19, 2006Date of Patent: June 10, 2008Assignee: Immunex CorporationInventors: Brian D. Follstad, Anne H. Potter
-
Patent number: 7067279Abstract: This invention relates generally to the field of cell culture. More particularly, the invention relates to improving viability of recombinant cell cultures and the yields of secreted polypeptides therefrom by the addition of betaine to the tissue culture medium.Type: GrantFiled: August 23, 2002Date of Patent: June 27, 2006Assignee: Immunex CorporationInventors: Brian D. Follstad, Anne H. Potter
-
Publication number: 20040115768Abstract: The invention provides media and methods for culturing mammalian cells whereby the sialylation of a protein produced by the cells is increased. The medium can contain N-acetylmannosamine and, optionally, galactose. The medium may also comprise fructose and mannose. Alternatively, the medium can contain galactose and fructose and, optionally, can also comprise mannose and/or N-acetylmannosamine. The methods can be practiced along with other methods for culturing cells so as to increase the quantity or quality of a protein produced by the cells, including culturing the cells at a temperature below 37° C.Type: ApplicationFiled: July 15, 2003Publication date: June 17, 2004Applicant: Immunex CorportationInventor: Brian D. Follstad